Filing Details
- Accession Number:
- 0001437749-20-021113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-13 20:35:05
- Reporting Period:
- 2020-07-17
- Accepted Time:
- 2020-10-13 20:35:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812702 | Marcus Schulz | C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway, Suite 310 Bothell WA 98021 | Vice President, Global Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-17 | 26,624 | $0.00 | 41,753 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-10-12 | 953 | $28.20 | 40,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The restricted stock was granted pursuant to the BioLife Solutions Inc. Second Amended and Restated 2013 Performance Incentive Plan, as amended, and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments.
- The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Billionaire Hedge Funds
